Nektar Therapeutics

$18.63
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.61 (-3.17%) Today

$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell NKTR and other stocks, options, and ETFs commission-free!

About NKTR

Nektar Therapeutics Common Stock, also called Nektar Therapeutics, is a biopharmaceutical company, which engages in applying technology platforms to develop novel drug candidates. The firm focuses on the therapies for cancer, autoimmune disease, and chronic pain.

CEO

Howard W. Robin

Employees

718

Headquarters

San Francisco, California

Founded

1990

Market Cap

3.57B

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

729.23K

High Today

$19.13

Low Today

$18.49

Open Price

$19.13

Volume

835.09K

52 Week High

$26.75

52 Week Low

$15.40

Analyst Ratings

43%

of 14 ratings

Buy

43%

Hold

57%

Sell

NKTR Earnings

-$0.74

-$0.49

-$0.25

$0.00

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Estimated

— per share

Actual

Expected May 6, After Hours